Login or sign up
For business

Map pharmaceuticals

3.7· 7 reviews
Average ratingAverage
3.7/ 5

Based on 7 reviews

514%
443%
343%
20%
10%
Tanya Kawai-Bruckner
Reviews 1

I recently had the pleasure of engaging with a pharmaceutical company that left a lasting impression on me. The website was not only user-friendly but also informative, providing a comprehensive overview of their products and services. The attention to detail and transparency in their approach instilled a sense of trust and reliability. The quality of their products was top-notch, and the customer service was outstanding. The company's commitment to innovation and customer satisfaction truly sets them apart. I wholeheartedly recommend this company to anyone seeking high-quality pharmaceutical solutions.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Map pharmaceuticals

MAP Pharmaceuticals, Inc., a development stage company, focuses on developing novel inhalation therapies for respiratory and systemic diseases. It has various proprietary product candidates in clinical development, including Unit Dose Budesonide for pediatric asthma in children from six months to eight years of age and MAP0004 for migraine. The company's product portfolio also includes MAP0005 for the treatment of adolescent and adult asthma, and chronic obstructive pulmonary disease; and MAP0001 for the treatment of Type 1 and Type 2 diabetes via pulmonary delivery using its Tempo inhaler. MAP Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Mountain View, California.

Categories
Pharmaceuticals